Tarpeyo Interactions
There are 477 drugs known to interact with Tarpeyo (budesonide), along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 58 are major, 397 are moderate, and 22 are minor.
- View all 477 medications that may interact with Tarpeyo
- View Tarpeyo alcohol/food interactions (1)
- View Tarpeyo disease interactions (7)
Most frequently checked interactions
View interaction reports for Tarpeyo (budesonide) and the medicines listed below.
- Auryxia (ferric citrate)
- ciprofloxacin
- cyanocobalamin
- doxycycline
- Duavee (bazedoxifene / conjugated estrogens)
- Enbrel (etanercept)
- famotidine
- fluconazole
- Gardasil 9 (human papillomavirus vaccine)
- Humira (adalimumab)
- hydralazine
- ibuprofen
- irbesartan
- Kayexalate (sodium polystyrene sulfonate)
- Lokelma (sodium zirconium cyclosilicate)
- losartan
- metformin
- Nucala (mepolizumab)
- omega-3 polyunsaturated fatty acids
- omeprazole
- omeprazole / sodium bicarbonate
- Omnipaque 350 (iohexol)
- Otezla (apremilast)
- Paxlovid (nirmatrelvir / ritonavir)
- phenazopyridine
- Procrit (epoetin alfa)
- Rena-Vite Rx (multivitamin)
- Tremfya (guselkumab)
- Vitamin B12 (cyanocobalamin)
Tarpeyo alcohol/food interactions
There is 1 alcohol/food interaction with Tarpeyo (budesonide).
Tarpeyo disease interactions
There are 7 disease interactions with Tarpeyo (budesonide) which include:
- hepatic impairment
- hepatic impairment
- hyperadrenocorticism
- infections
- ocular herpes simplex
- ocular toxicities
- osteoporosis
More about Tarpeyo (budesonide)
- Tarpeyo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glucocorticoids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.